NAM has a range of email bulletins to keep you up to date and in the loop with the latest research, news and developments in HIV. Listed below are the different bulletins we offer so you can decide which ones are going to be the most helpful to you.

We recommend that you add the bulletin email address to your safe senders list, contacts list or address book, so that it reaches your inbox and doesn't end up in your junk or spam folder. If you need help with this, please get in touch with us at or call 020 7837 6988.

HIV update

HIV update is sent out fortnightly. It offers a summary of key developments in HIV research relevant to people living with HIV in the UK, giving links to more detailed articles and other sources of information.

Sign up on the left to receive HIV update. Plain text versions of HIV update are also available and can be found in the archive.

If you no longer want to receive HIV update, please unsubscribe.

aidsmap news

NAM’s aidsmap news bulletin is also sent out fortnightly (alternate week to HIV update). This bulletin offers unique and comprehensive global coverage of HIV & AIDS related research and developments.

Sign up on the left to receive aidsmap news.

If you no longer want to receive aidsmap news, please unsubscribe.

aidsmap insight

NAM's aidsmap insight bulletin is a daily (Monday to Friday) summary of news from the NAM editorial team, along with our editors' picks of the day from other news outlets. The insight bulletin also highlights the most popular news stories on

Sign up on the left to receive aidsmap insight.

If you no longer want to receive aidsmap insight, please unsubscribe.


In April 2017, NAM published its first sexual health and HIV policy EUROBulletin, which was previously delivered by MEDFASH.

The EUROBulletin is published quarterly and provides information about policies, programmes, standards, guidance, evidence and research, and emerging issues in sexual and reproductive healthcare, HIV treatment and care, prevention and sexual health promotion in Europe.

Sign up to receive the EUROBulletin and read previous editions.

If you no longer want to receive the EUROBulletin, please unsubscribe.

Conference bulletins

During major international conference such as the Conference on Retroviruses and Opportunistic Infections (CROI), the International AIDS Conference and the International AIDS Society conference, we send out daily email bulletins summarising our news coverage of research presented at the conference.

We have also covered news and sent out bulletins during other conferences. These include the HIV Glasgow conference, the European AIDS Society Conference and the International Harm Reduction Conference.

You can sign up to receive these news bulletins, or if you sign up for one of our other bulletins you will receive the conference bulletins automatically.

We also offer these bulletins in a range of other languages, including French, Spanish, Portuguese and Russian.

Please be aware that these conferences are usually in February/March and June/July, so if you sign up to only receive conference bulletins you will not receive bulletins at other times.

If you no longer want to receive our conference bulletins, please unsubscribe.


Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.